Core Viewpoint - UTime Limited has entered into a definitive securities purchase agreement with five institutional investors for the purchase of 22,727,275 units, which include Class A ordinary shares and Series A warrants, at a price of $1.10 per unit, aiming to raise approximately $25 million in gross proceeds [1][2][3]. Group 1: Offering Details - The offering consists of Class A ordinary shares and Series A warrants, with each warrant having an exercise price of $1.10 per share and expiring six months after issuance [3]. - The transaction is expected to close around October 17, 2025, pending customary closing conditions [3]. - The offering is conducted under a shelf registration statement previously filed and declared effective by the SEC [4]. Group 2: Company Overview - UTime Limited specializes in consumer electronics and mobile communications, focusing on the design, development, and manufacture of smartphones, feature phones, and related accessories [6]. - The company operates through both OEM/ODM services and proprietary brands, providing end-to-end product solutions that include hardware design, software customization, and after-sales support [6]. - UTime's principal business activities include contract manufacturing, in-house development of smart devices, integration of new technologies like IoT and 5G, and supply-chain management services [6].

Core Viewpoint - Big Tree Cloud Holdings Limited has successfully completed a registered direct offering, raising approximately $5.0 million through the sale of 8,064,516 ordinary shares at a price of $0.62 per share [1][2]. Company Overview - Big Tree Cloud, founded in 2020, is an international capital platform focused on strategic investment and industrial integration within China's personal care industry. The company emphasizes scientific research, innovation, and technological advancement, aiming to enhance supply chain synergy and improve efficiency [5]. Offering Details - The offering was conducted with Aegis Capital Corp. as the exclusive placement agent, and the gross proceeds before fees and expenses amounted to approximately $5.0 million [2][3]. - The offering was made under an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) [3]. Use of Proceeds - The net proceeds from the offering are expected to be utilized for general corporate purposes and working capital [2].

Core Viewpoint - WORK Medical Technology Group LTD has announced a registered direct offering of 38,999,334 Class A ordinary shares at a price of $0.075 per share, aiming to raise approximately $2.9 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of Class A ordinary shares or pre-funded warrants at a purchase price of $0.075 per share, with the pre-funded warrants having an exercise price of $0.0005 per share [1]. - The transaction is expected to close on or about September 26, 2025, pending customary closing conditions [2]. - The offering is made under a shelf registration statement on Form F-3, which was declared effective by the SEC on September 15, 2025 [3]. Group 2: Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company has sold products in 34 provincial-level regions in China and has 15 products available in over 30 countries globally [5]. - WORK Medical has received various quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [5].

Core Viewpoint - Boxlight Corporation has announced a registered direct offering of common stock, aiming to raise approximately $4 million through the sale of 1,333,333 shares at a price of $3.00 per share [1]. Group 1 - Boxlight Corporation is recognized as a leader in educational technology on a global scale [1]. - The securities purchase agreements were made with certain institutional investors [1]. - The offering is priced at-the-market under Nasdaq rules [1].

Core Viewpoint - Ryde Group Ltd has announced a securities purchase agreement to raise approximately US$1.6 million through the sale of Class A shares at US$0.25 each [1] Group 1: Company Overview - Ryde Group Ltd is a leading technology platform for mobility and quick commerce, headquartered in Singapore [1] - The company is listed on NYSE American under the ticker symbol RYDE [1] Group 2: Financial Details - The offering consists of 6,422,000 Class A shares [1] - The gross proceeds from the offering are approximately US$1.6 million before deducting offering expenses [1] - The offering is a registered direct offering priced at-the-market under NYSE American rules [1] Group 3: Offering Structure - The company did not engage any placement agent for the offering [1]

Core Points - STRATA Skin Sciences, Inc. has successfully closed a registered direct offering, issuing 1,097,547 shares of common stock at a price of $2.204 per share [1][2] - The gross proceeds from this offering amounted to approximately $2.42 million, which will be utilized for working capital and general corporate purposes [2] - The offering was conducted under a shelf registration statement declared effective by the SEC on December 18, 2024, with a prospectus supplement filed on September 3, 2025 [3] Company Overview - STRATA Skin Sciences is focused on developing, commercializing, and marketing innovative products for treating dermatologic conditions, including psoriasis, vitiligo, and acne [4] - The company's product lineup features the XTRAC excimer laser, VTRAC lamp systems, and the TheraClearX Acne Therapy System [4] - STRATA employs a unique Partnership Program that offers a fee per treatment cost structure, on-site training, service and maintenance, and co-op advertising support [5]

Core Viewpoint - STRATA Skin Sciences, Inc. has announced a registered direct offering of 1,097,547 shares of common stock at a price of $2.204 per share, aiming to raise approximately $2.42 million for working capital and general corporate purposes [1][3]. Group 1: Offering Details - The offering is being facilitated by Ladenburg Thalmann & Co. Inc. as the exclusive placement agent, with the closing expected around September 4, 2025, pending customary closing conditions [2]. - The gross proceeds from the offering, before deducting fees and expenses, are projected to be about $2.42 million [3]. Group 2: Company Overview - STRATA Skin Sciences is focused on developing and marketing innovative products for dermatologic conditions, including psoriasis, vitiligo, and acne, with products like the XTRAC excimer laser and TheraClearX Acne Therapy System [6]. - The company employs a unique Partnership Program that offers a fee per treatment cost structure, providing on-site training, service, maintenance, and advertising support to practices [7].

Core Points - AirNet Technology Inc. has entered into a definitive agreement for the purchase and sale of 80,826,225 ordinary shares and accompanying warrants at a combined purchase price of $2.227 per share and warrant [1] - The gross proceeds from the offering are expected to be approximately $180.0 million before deducting offering expenses [1] - The offering is expected to close on or about August 27, 2025, subject to customary closing conditions [1] Financial Details - The warrants are immediately exercisable at an exercise price of $3.3405 per ordinary share and will expire five years from the date of issuance [1] - The net proceeds from the offering will be used for general corporate and working capital purposes [2] Regulatory Information - The securities will be offered pursuant to an effective "shelf" registration statement on Form F-3 previously filed with the SEC [3] - Additional information regarding the offering will be included in a current report on Form 6-K to be furnished by the Company to the SEC [2][3]

Core Viewpoint - Ocugen, Inc. has entered into a securities purchase agreement with Janus Henderson Investors to raise capital through a registered direct offering of common stock and warrants, aiming to enhance its financial position for ongoing gene therapy developments for blindness diseases [1][3]. Group 1: Offering Details - The company will sell 20,000,000 shares of common stock at a price of $1.00 per share, with warrants to purchase an additional 20,000,000 shares at an exercise price of $1.50 per share [1][3]. - The gross proceeds from the offering are expected to be approximately $20 million, with potential additional proceeds of up to $30 million if the warrants are fully exercised [3]. - The offering is expected to close on or about August 11, 2025, subject to customary closing conditions [3]. Group 2: Company Background - Ocugen, Inc. is a biotechnology leader focused on gene therapies for blindness diseases, utilizing a modifier gene therapy platform to address complex diseases caused by imbalances in multiple gene networks [5]. - The company is developing programs for inherited retinal diseases and other blindness conditions affecting millions globally, including retinitis pigmentosa and Stargardt disease [5].

Core Viewpoint - ParaZero Technologies Ltd. has announced a registered direct offering to institutional investors, aiming to raise approximately $2.2 million through the sale of ordinary shares and pre-funded warrants at a price of $1.10 per share [1][3]. Group 1: Offering Details - The offering includes the sale of 2,000,001 ordinary shares or pre-funded warrants at a public offering price of $1.10 per ordinary share [2]. - Pre-funded warrants are immediately exercisable and can be exercised at any time until fully exercised, with a one-for-one decrease in the number of ordinary shares for each pre-funded warrant sold [2]. - The transaction is expected to close on or about August 5, 2025, pending customary closing conditions [3]. Group 2: Use of Proceeds - The net proceeds from the offering, along with existing cash, are intended for general corporate purposes and working capital [3]. Group 3: Company Overview - ParaZero Technologies Ltd. is an aerospace defense company specializing in smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry [7]. - The company was founded in 2014 and is recognized for its advanced drone technologies, supporting various commercial, industrial, and governmental operations worldwide [7]. - Key products include SafeAir (an autonomous parachute recovery system), DefendAir (a counter-UAS net-launching platform), and DropAir (a precision aerial delivery system) [7].